Markets Wired

Humana Inc (NYSE:HUM) close to 52-week high, short interest decreasing

June 16
08:33 2015

Humana Inc (NYSE:HUM) (TREND ANALYSIS) shares were traded with a quadrupled volume. The stock closed last trading session at $206.58, down by -2.77%, with a volume of 8,060,491 shares against an average volume for the last 3 months of 1,727,090.

Stock Performance: Click here for a free comprehensive Trend Analysis Report

Humana Inc (NYSE:HUM) stock is currently trading 6.01% below its 52-week-high, 78.84% above its 52-week-low. The 1-year stock price history is in the range of $115.51 – $219.79. Humana Inc (HUM) has a price to earnings ratio of 26.46 versus Healthcare sector average of 26.69. HUM stock price has outperformed the S&P 500 by 41.9%. The Medical HMO company is currently valued at $30.94 billion and its share price closed the last trading session at $206.58. The stock has a 50-day moving average of $186.76 and a 200-day moving average of $165.65.

Humana Inc (HUM) current short interest stands at 4.07 million shares. It has decreased by 9% from the same period of last month. Around 3% of the company’s shares, which are float, are short sold. With a 10-days average volume of 3.22 million shares, the number of days required to cover the short positions stand at 1.3 days.

The company is expected to announce next quarter earnings on July 29, at consensus estimate of $2.45. Humana Inc (HUM) reported last quarter earnings on April 29. The Medical HMO company announced earnings per share of $2.47 against a consensus Street estimate of $2.54, missing estimate by $0.07. This corresponds to an increase of $0.19 compared to the same quarter of the previous fiscal year.

Is this a Buying Opportunity? Click here for a free Trend Analysis Report

There are currently twenty analysts that cover Humana Inc stock. Of those twenty, seven have a Buy rating, twelve have a Hold rating and one has a Sell rating. On a consensus basis this yields to an Overweight rating. The consensus target price stands at $185.59.

A recent analyst activity consisted of Sterne Agee upgrading their Underperform rating to Neutral on June 3. On the date of report, the stock closed at $213.61.

Deutsche Bank reiterated their Hold stance on June 1, and increased their price target on HUM stock from $155 to $220. This corresponds to a 6.5% upside from the last closing price. On the date of report, the stock closed at $214.92.

Another research firm was Leerink Swann who reiterated their Outperform stance on June 1. Leerink Swann increased their price target on Humana Inc from $200 to $220. This translates to a 6.5% upside from the last closing price. On the date of report, the stock closed at $214.92.

Company profile

Humana Inc. is a managed health care company with medical members located in the United States and Puerto Rico. The Company offers coordinated health care through health maintenance organizations, preferred provider organizations, point-of-service plans, and administrative services products. Humana offers its products to employer groups, government-sponsored plans, and individuals.

About Author

Ann Garaghty

Ann Garaghty

Ann Garaghty joined Markets Wired in October 2013 as an Internet & Media analyst. Prior to her current role, Ann was a sell-side analyst at Evercore Partners.

Related Articles